Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
Status:
Completed
Trial end date:
2017-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand why patients in the World Trade Center program
have continuing breathing problems. This study will improve investigators understanding of
breathing problems among individuals with World Trade Center exposure by allowing them to
review and monitor medication use, lung function, and examine other conditions that can
contribute to problems with breathing. The findings from the study will help investigators
understand why some people have persistent lower respiratory symptoms (breathing problems)
after their exposure to World Trade Center dust and fumes, and may help guide better
management and treatment of these symptoms.
Phase:
N/A
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborator:
National Institute for Occupational Safety and Health (NIOSH/CDC)
Treatments:
Fluticasone Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Xhance